Search

A 37-year-old male patient was admitted to our hospital with recurrent hemoptysis, 50 mL per day. Thoracic computed tomography showed no pathology responsible for hemoptysis. Bronchoscopy revealed mucosal infiltrations and 2 to 3-mm blotch in the lateral wall of the right lower lobe. After punch biopsy of the suspected area, massive bleeding occurred. Right lower bilobectomy was performed urgently. A bronchovascular fistula was noticed at the specimen. Pathological examination result was compatible with clinically suspected Behçet"s disease. The patient was given high-dose steroid and cyclophosphamide treatment and received azathioprine maintenance treatment for 18 months. He has been symptom-free for three-year follow-up.

Amaç: Akciğer kanseri dünyada kanserden ölümlerin ilk sırasında yer almaktadır. Günümüzde yeni geli?en tanısal metotlara, ilerlemi? cerrahi tekniklere ve cerrahi dı?ı tedavi yöntemlerindeki geli?melere rağmen, genel olarak akciğer kanserinin be? yıllık kümülatif sağ kalımı hala %14’tür. Gereç ve Yöntem: Postoperatif histopatolojik inceleme sonucunda erken evre (Evre I - II) olarak değerlendirilen 207 olgunun kayıtları retrospektif olarak gözden geçirildi. Çalı?mamızda olgularımızın ya?, cins, solunum fonksiyonları, ?ikayetleri, postoperatif komplikasyonlar, tümörün evresi ve histopatolojik tipinin prognoza ve sağ kalıma olan etkileri ara?tırılmı?tır. Bulgular: Çalı?mamızda dü?ük evre tümörlerde cinsiyet, tanı sırasında ?ikâyeti olma/olmama durumu, göğüs ağrısı, hemoptizi, balgam, dispne ve sigara anamnezi sağ kalımı istatistiksel olarak etkilememi?tir. TNM evresi ve postoperatif komplikasyon varlığı sağ kalım süresini anlamlı olarak etkilemi?tir. Sonuç: Küçük hücreli dı?ı akciğer kanserinde (KHDAK) küratif tedavi ?ekli cerrahidir. KHDAK’li hastaların prognozunu belirleyen en önemli kriter evredir., Aim: Lung cancer is at the beginning causes of deaths from cancer in the world. Despite recent advances in diagnostic methods, advanced surgical techniques, and non-surgical methods of treatment, overall 5-year cumulative survival of lung cancer is still 14%. Materials and Methods: As a result of postoperative histopathological examination, the records of 207 patients who were evaluated as early stage (stage I and II) were retrospectively reviewed. We investigated the age, gender, respiratory functions, complaints, and postoperative complications, prognosis of the tumor stage and histopathologic type and the effects of survival in our study. Results: Low grade tumors, gender, presence / absence of complaints during diagnosis, chest pain, hemoptysis, sputum, dyspnea and smoking history did not affect survival statistically. TNM stage and postoperative complications significantly affected the survival time. Conclusion: Curative therapy in non-small cell lung cancer is surgery. The most important criteria determining the prognosis of patients is stage.

Amaç: Bu çalışmada akciğer kanserli hastalarda mediastinal evrelemede standart mediastinoskopi (SM) ile video yardımlı mediastinoskopi (VAM) güvenlilik profili, komplikasyon oranları, mediastinal istasyon ve lenf nodu sayısı açısından karşılaştırıldı. Ça­lış­ma­pla­nı:­Ocak 2006 - Ocak 2011 tarihleri arasında küçük hücreli dışı akciğer kanseri (KHDAK) tanısı ile kliniğimize başvuran ve cerrahi yapılması planlanan 551 hastanın verisi retrospektif olarak incelendi. Hastaların yaşı ve cinsiyeti ve tümör hücresi tipi kaydedildi. Hastaların 36sına (%65.5) SM yapılmış iken 190 (%34.5) hastaya VAM yapılmış idi. Bul gu lar: Video yardımlı mediastinoskopi yapılan hastaların %63.2sine (n=96) ve SM yapılan hastaların %70.1ine (n=218) skuamöz hücreli karsinom tanısı kondu. standart mediastinoskopi yapılan 361 hastanın 66sında (%18.3) ve VAM yapılan 190 hastanın 60ında (%31.6) N2 nodal tutulum tespit edildi (p

Every patient undergoing curative treatment for primary lung cancer is a candidate for metachronous lung cancer, with a reported risk of 5% per year. The majority of cases are stage I patients. Patients who undergo resection for lung cancer should be followed regularly. A metachronous lung cancer that develops as bilateral synchronous lung cancer is very rare.

Background. Carcinosarcoma of the lung is a rare malignant neoplasm. We evaluated the diagnosis and treatment of six carcinosarcoma cases, including a synchronous tumour and a solitary pulmonary tumour, along with the clinical and histological features and survival times. Methods. From a retrospective analysis of 1076 non-small-cell lung cancer resections performed between January 1996 and January 2011, six patients (0.5%) with pulmonary carcinosarcoma (all males; mean age 58 years; range 53–66) who underwent surgical treatment were studied. Results. The mean tumour pathological T diameter was 7.2 cm (median 6 cm, range 3–14.5 cm). Only one patient was diagnosed with carcinosarcoma preoperatively. The clinical presentation and tumour localisations differed. The operations performed were a lobectomy (n=4), pneumonectomy (n=1), and bilobectomy (n=1). Histologically, the epithelial characteristics of the tumours were consistent with squamous cell carcinoma in most of the patients. A complete resection was performed in all six patients. No mortality occurred in the early postoperative period. The median survival time was 9 (3–25) months. Conclusion. The preoperative diagnosis of carcinosarcoma of the lung is difficult due to the composition of the different histopathological structures. Complete surgical resection is the treatment of choice for pulmonary carcinosarcoma, although further studies are needed.